findmyKOL

Baharak Moshiree, MD

Enriched profile

Professor of Medicine and Director of Motility, Division of Gastroenterology · Wake Forest University School of Medicine

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Charlotte, NC · Southeast · United StatesSpecialtyGastroenterologyFocusIBS / Functional GI
Active KOLfindmyKOL type: EliteLatest publication2025Online presenceverified 2026Payments2021–2025NIH funding2023–2026Why? →

Baharak Moshiree is Professor of Medicine and Director of Motility, Division of Gastroenterology at Wake Forest University School of Medicine. ClinicalTrials.gov lists 6 registered studies with this person as an investigator.

Data verified 17 Aug 2026

Overview

Updated 14 Oct 2026

Baharak Moshiree, MD, is Professor of Medicine and Director of Motility, Division of Gastroenterology at Wake Forest University School of Medicine / Atrium Health, Charlotte, NC. The public record shows 122 publications with 1,960 citations (h-index 23), centered on IBS / Functional GI. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 18 companies, 1 NIH-funded awards (2023–2026).

  • Top research focus: IBS / Functional GI
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 18 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
IBS / Functional GI3 trialsBlind Loop Syndrome1 trialCystic Fibrosis1 trialCysts1 trialParesis1 trialGastroparesis1 trial

Research focus

OpenAlex concept fingerprint
IBS / Functional GI

Drugs & molecules

across trials, industry payments and publications
XIFAXANgeneric · RifaximinClinical trials—Industry payments18Publications—Ibsrelageneric · TenapanorClinical trials—Industry payments12Publications—Trulancegeneric · PlecanatideClinical trials—Industry payments9Publications—Motegritygeneric · PrucaloprideClinical trials—Industry payments2Publications—Voqueznageneric · VonoprazanClinical trials—Industry payments2Publications—Dupixentgeneric · DupilumabClinical trials—Industry payments1Publications—Givlaarigeneric · GivosiranClinical trials—Industry payments1Publications—Linzessgeneric · LinaclotideClinical trials—Industry payments1Publications—Rezdiffrageneric · ResmetiromClinical trials—Industry payments1Publications—Sancusogeneric · GranisetronClinical trials—Industry payments1Publications—Skyrizigeneric · RisankizumabClinical trials—Industry payments1Publications—Zenpepgeneric · Amylase / lipase / proteaseClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Salix Pharmaceuticals, a division of Bausch Health US, LLCClinical trials—Industry payments27Ardelyx, Inc.Clinical trials—Industry payments13Medtronic, Inc.Clinical trials—Industry payments6University of FloridaClinical trials4Industry payments—Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments3Phathom Pharmaceuticals, Inc.Clinical trials—Industry payments2Abbvie Inc.Clinical trials—Industry payments1Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments1Blueprint Medicines CorporationClinical trials—Industry payments1CapsoVision, Inc.Clinical trials—Industry payments1Chris GossClinical trials1Industry payments—Coloplast CorpClinical trials—Industry payments1Cumberland Pharmaceuticals, Inc.Clinical trials—Industry payments1E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments1Enterra Medical, Inc.Clinical trials—Industry payments1Genzyme CorporationClinical trials—Industry payments1GI Supply, Inc.Clinical trials—Industry payments1Ironwood Pharmaceuticals, IncClinical trials—Industry payments1Madrigal PharmaceuticalsClinical trials—Industry payments1Nestle HealthCare Nutrition Inc.Clinical trials—Industry payments1Wake Forest University Health SciencesClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
23h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials ↓
18companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2023–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

18 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    100%
    Guanylate Cyclase-C Agonist39.5%
    Linzess65%Trulance35%
    Part D<11 patients
    Proton pump inhibitor33.2%
    Omeprazole35%Dexlansoprazole Dr24%Pantoprazole Sodium23%Lansoprazole18%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/baharak-moshiree-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • X / Twitter

    x.com/bmoshiree

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Other

    gi.org/2025/03/06/womens-history-month-2025

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →gi.org ↗
  • X / Twitter

    x.com/AmCollegeGastro/status/1899864413760299034

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    University of Florida College of Medicine

    2000
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →school.wakehealth.edu ↗
  • MSc

    Clinical Investigation, University of Florida

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atriumhealth.org ↗
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acg2025.eventscribe.net ↗
  • Board Certified

    Gastroenterology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atriumhealth.org ↗

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • Podcast guest

    "IBS-C Treatment Options: What Patients Should Know", Gastro Girl

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →gastrogirl.com ↗
  • Podcast guest

    "What a Patient and Doctor Want You to Know About Gastroparesis", Gastro Girl

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →gastrogirl.com ↗
  • Podcast guest with Brian Lacy

    MD, on Irritable Bowel Syndrome (Part 1), Gastroenterology Learning Network (HMP Global)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hmpgloballearningnetwork.com ↗
  • Podcast guest with Brian Lacy

    MD, on IBS (Part 2), Gastroenterology Learning Network (HMP Global)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hmpgloballearningnetwork.com ↗
  • Featured interview

    "Conversations with Women in GI: Baharak Moshiree, MD", American College of Gastroenterology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pop.gi.org ↗
  • Featured speaker

    "Disorders of the Colon and Rectum", IFFGD Norton Education Series (30th Anniversary)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iffgd.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.